Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Artículo en Ruso | MEDLINE | ID: mdl-37382984

RESUMEN

OBJECTIVE: To establish the structural features of the brain (cortical and subcortical) in depressive patients at clinical risk for psychosis. MATERIAL AND METHODS: Nineteen right-handed male patients with youth depression, who were assessed for high risk of psychotic manifestation, and 20 healthy controls underwent MRI and clinical examination. T1-weighted images were processed in FreeSurfer 7.1.1. For each subject average values for the cortex thickness and area, volumes of subcortical structures, and separately volumes of the amygdala nuclei were obtained. Intergroup comparisons and correlations with clinical scales (SOPS, HDRS) were calculated. RESULTS: Patients showed decreased gray matter thickness in the left (p=0.002) and right (p=0.003) postcentral gyri and increased thickness in the right posterior cingulate cortex (p=0.003) and rostral anterior cingulate cortex (p=0.001). CONCLUSION: These findings may reflect cortical changes at early stages of the psychotic process, including the gray matter loss in some areas and the opposite phenomena in others (it cannot be ruled out that the latter may be the result of altered ontogenesis and/or certain compensatory changes).


Asunto(s)
Depresión , Trastornos Psicóticos , Humanos , Adolescente , Masculino , Depresión/diagnóstico por imagen , Encéfalo/diagnóstico por imagen , Trastornos Psicóticos/diagnóstico por imagen , Sustancia Gris/diagnóstico por imagen , Amígdala del Cerebelo
3.
QJM ; 111(5): 303-306, 2018 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-29432601

RESUMEN

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in patients with chronic obstructive pulmonary disease (COPD) and such patients tend to carry a heavy burden of risk factors for CVD. There is little information on the documentation and management of CVD risk factors in COPD patients. AIM: To audit the recording and management of CVD risk factors in 200 COPD patients attending the respiratory out-patient clinics at two University teaching hospitals. DESIGN: Retrospective analysis of hospital records. RESULTS: While there was reasonable recording of a history of CVD risk factors such as hypertension and hyperlipidaemia, the actual recording of risk factor levels was poor-blood pressure and heart rate were recorded in less than half of subjects; lipids, waist circumference, HbA1c and height were essentially not recorded at all. CONCLUSIONS: Best practice guidelines and standard operating procedures for CVD risk factor recording and control require to be developed if the major cause of death in COPD subjects, CVD, is to be addressed. An outline for a standard operating procedure is presented in the Appendix. Serial audits will be required to assess the efficacy of such measures.


Asunto(s)
Enfermedades Cardiovasculares/etiología , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Presión Sanguínea/fisiología , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/prevención & control , Femenino , Frecuencia Cardíaca/fisiología , Humanos , Irlanda/epidemiología , Masculino , Auditoría Médica , Registros Médicos/normas , Persona de Mediana Edad , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Estudios Retrospectivos , Factores de Riesgo
4.
Eur J Prev Cardiol ; 21(7): 813-22, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23147276

RESUMEN

BACKGROUND: Despite the fact that subjects with established coronary heart disease (CHD) are at high risk of further events and deserve meticulous secondary prevention, current audits such as EUROASPIRE show poor control of major risk factors. Ongoing monitoring is required. We present a new risk factor audit system, SURF (Survey of Risk Factor management), that can be conducted much more quickly and easily than existing audit systems and has the potential to allow hospitals of all sizes to participate in a unified international audit system that will complement EUROASPIRE. Initial experience indicates that SURF is truly simple to undertake in an international setting, and this is illustrated with the results of a substantive pilot project conducted in Europe and Asia. METHODS: The data collection system was designed to allow rapid and easy data collection as part of routine clinic work. Consecutive patients (aged 18 and over) with established CHD attending outpatient cardiology clinics were included. Information on demographics, previous coronary medical history, smoking history, history of hypertension, dyslipidaemia or diabetes, physical activity, attendance at cardiac rehabilitation, cardiac medications, lipid and glucose levels (and HbA1c in diabetics) if available within the last year, blood pressure, heart rate, body mass index, and waist circumference were collected using a one-page data collection sheet. Years spent in full time education was added as an additional question during the pilot phase. RESULTS: Three European countries - Ireland (n = 251), Belgium (n = 122), and Croatia (n = 124) - and four Asian countries - Singapore (n = 142), Taiwan (n = 334), India (n = 97), and Korea (n = 45) - were included in the pilot study. The results of initial field testing were confirmed in that it proved possible to collect data within 60-90 seconds per subject. There was poor control of several risk factors including high levels of physical inactivity (41-45%), overweight and obesity (59-78%), and ongoing smoking (15%). There were lower levels of individuals attending cardiac rehabilitation in Asia. More Europeans than Asians reached the low-density lipoprotein cholesterol target of <2.5 mmol/l (66 vs. 59%) reflecting differences in medication usage. However, blood pressure control was superior in Asia, with 71% <140/90 compared with 66% of Europeans (NS). CONCLUSIONS: This phase of SURF has confirmed its ease of use which should allow wide participation and the collection of representative risk factor data in subjects with CHD as well as ongoing data collection to monitor secular trends in risk factor control. Notwithstanding that this is a pilot study, the results suggest that risk factor control, particularly for lifestyle-related measures, is poor in both Europe and Asia.


Asunto(s)
Enfermedad Coronaria/etiología , Hipertensión/complicaciones , Adulto , Anciano , Asia , Presión Sanguínea , Enfermedad Coronaria/prevención & control , Recolección de Datos , Complicaciones de la Diabetes , Manejo de la Enfermedad , Europa (Continente) , Femenino , Humanos , Masculino , Auditoría Médica , Persona de Mediana Edad , Proyectos Piloto , Factores de Riesgo , Prevención Secundaria , Factores Sexuales
6.
Ir Med J ; 102(4): 113-6, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19552291

RESUMEN

The EUROASPIRE III audit was a Europe-wide study which took place in 2006/2007. The objective was to examine the control of risk factors in subjects with established cardiovascular disease. Here, we compare the Irish results to those of the other 21 European countries which participated. Control of blood cholesterol was significantly better in Irish participants, with 73% below the target of 4.5 mmol/l. Blood pressure control was less satisfactory in both Irish and European individuals, with an average of 52% of Irish participants not achieving blood pressure targets. Medication usage was high throughout, particularly anti-platelet agents, beta-blockers and, especially in Ireland, statins. Obesity figures were particularly high in Ireland and throughout Europe, with 82% Irish men and women either overweight or obese. Smoking figures in Irish women were also of concern, with 24% continuing to smoke. Cardiac rehabilitation attendance was particularly high in Ireland, with 68% attending; substantially higher than the European figure of 34%. In common with the rest of Europe, current control of body weight and blood pressure in Ireland is unsatisfactory and in need of increased consideration on the part of both patients and healthcare professionals.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Prevención Secundaria , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/etiología , Colesterol/sangre , Europa (Continente)/epidemiología , Femenino , Humanos , Hipercolesterolemia/complicaciones , Hipertensión/complicaciones , Irlanda/epidemiología , Masculino , Obesidad/complicaciones , Factores de Riesgo
7.
Atherosclerosis ; 206(2): 611-6, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19375079

RESUMEN

OBJECTIVE: We aimed to clarify some previous inconsistencies regarding the role of high density lipoprotein cholesterol (HDL-C) as a CVD protective factor. METHODS: The SCORE dataset contained data on HDL-C for 104,961 individuals (45% women) without pre-existing coronary heart disease (CHD). These were from 7 pooled European prospective studies. The effect of HDL-C, both in quintiles and as a continuous variable, on risk of CVD and CHD mortality was examined, using Cox proportional hazards model, adjusted for age, total cholesterol, systolic blood pressure, smoking, diabetes and body mass index and stratified by gender, age group, country and category of SCORE CVD risk. RESULTS: A strong, graded, independent, inverse relationship between HDL-C and both CVD and CHD mortality was demonstrated. Adjusted hazard ratios per 0.5mmol/l increase in HDL-C were 0.60 (0.51, 0.69) and 0.76 (0.70, 0.83) in women and men, respectively for the CVD mortality endpoint. The corresponding hazard ratios were 0.53 (0.42, 0.68) and 0.79 (0.64, 0.98) in elderly women and men, respectively. The relationship was significant in all SCORE CVD risk strata and age groups. CONCLUSIONS: This multivariable analysis, the largest of its kind to date, has confirmed the inverse, independent, strong and graded relationship between HDL-C and both CVD and CHD mortality. We have clarified previous suggestions that the relationship is stronger in women and that it applies in all age groups. This is the first prospective study to demonstrate the independent relationship specifically in healthy elderly women and to show that the relationship holds at all levels of total CVD risk.


Asunto(s)
Enfermedades Cardiovasculares/mortalidad , HDL-Colesterol/sangre , Anciano , Envejecimiento , Enfermedades Cardiovasculares/prevención & control , Enfermedad Coronaria/mortalidad , Diabetes Mellitus/mortalidad , Europa (Continente)/epidemiología , Femenino , Humanos , Masculino , Análisis Multivariante , Modelos de Riesgos Proporcionales , Riesgo
8.
Ir Med J ; 101(9): 285-6, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19051620

RESUMEN

We describe the case of an 18 year old lady who presented with chest pain, breathlessness and hypertension. The initial diagnosis of renal artery stenosis, while correct, was incomplete. The finding of a reduced right radial pulse suggested the possibility of a large vessel vasculitis. She was also found to have critical coronary artery disease that required stenting and aortic incompetence. Renal artery stenting was also performed. Additional investigations confirmed Takayasu's arteritis. With immunosuppressive therapy and stenting she is now well and normotensive but may require aortic valve replacement in the future.


Asunto(s)
Inmunosupresores/uso terapéutico , Arteritis de Takayasu/diagnóstico , Adolescente , Dolor en el Pecho/diagnóstico , Dolor en el Pecho/fisiopatología , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/fisiopatología , Enfermedad de la Arteria Coronaria/terapia , Femenino , Humanos , Hipertensión/fisiopatología , Obstrucción de la Arteria Renal , Arteritis de Takayasu/fisiopatología , Arteritis de Takayasu/cirugía
9.
Artículo en Ruso | MEDLINE | ID: mdl-18819407

RESUMEN

Investigation of hepatitis A (HA) outbreak developed in 2005 among workers of food stores networkwas performed using conventional epidemiologic diagnostics as well as methods of molecular epidemiology. In 14 of 15 ill persons, using polymerase chain reaction, HAV RNA was detected by PCR in serum obtained on 2 - 25 day of illness (mean - 9.3 days). In 10 cases it was possible to determine nucleotide sequence of VP1/VP2 region of HAV genome and perform phylogenetic analysis of obtained isolates. It was determined that all isolates belonged to subgenotype IA, had high degree of homology and grouped in one cluster. These findings demonstrate their descendance from one source of infection, which, with high degree of probability, was the cook who made salads from fresh vegetables. HAV strain, which caused this epidemic outbreak circulates in Saint Petersburg for a long time and was already detected in 2004. Importance of vaccination against HA for persons working in manufacturing and distribution of food and use of molecular epidemiologic methods of surveillance for this infection is underlined.


Asunto(s)
Utensilios de Comida y Culinaria , Brotes de Enfermedades , Virus de la Hepatitis A Humana/clasificación , Hepatitis A/epidemiología , Hepatitis A/transmisión , Adolescente , Adulto , Femenino , Hepatitis A/prevención & control , Hepatitis A/virología , Virus de la Hepatitis A Humana/genética , Virus de la Hepatitis A Humana/aislamiento & purificación , Humanos , Masculino , Persona de Mediana Edad , Epidemiología Molecular , Filogenia , ARN Viral/análisis , Federación de Rusia/epidemiología , Población Urbana , Proteínas Estructurales Virales/genética , Adulto Joven
10.
Artículo en Ruso | MEDLINE | ID: mdl-18193579

RESUMEN

Cortexin, nootropil and cerebrolysin have been used as neuroprotective medications in the acute period of ischemic stroke (IS). Clinical efficacy of cortexin and nootropil has been compared in 2 therapeutic series in 35 patients and that of cortexin and cerebrolysin--in 45 patients. The efficacy was assessed using several clinical and psychometric scales with statistical processing of the results. The data obtained suggest that in patients with moderate IS the drugs exert a similar and rather marked effect which was stronger comparing to the treatment without these drugs. At the same time, a domestic neuroprotector cortexin has some advantages, especially with regard to the absence of side-effects and "price-dose-therapeutic effect" criterion.


Asunto(s)
Aminoácidos/uso terapéutico , Isquemia Encefálica/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Péptidos/uso terapéutico , Piracetam/uso terapéutico , Anciano , Encéfalo/efectos de los fármacos , Isquemia Encefálica/diagnóstico por imagen , Isquemia Encefálica/psicología , Ecoencefalografía , Femenino , Estudios de Seguimiento , Humanos , Péptidos y Proteínas de Señalización Intercelular , Masculino , Persona de Mediana Edad , Psicometría/métodos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...